About Cryo-Cell
Cryo-Cell is a company based in Oldsmar (United States) founded in 1989.. The company has 82 employees as of November 30, 2024. Cryo-Cell has completed 1 acquisition, including CORD:USE Cord Blood. Cryo-Cell operates in a competitive market with competitors including China Cord Blood Corporation, BioLife Plasma Services, Cellcolabs, FamilyCord and Lazo de Vida, among others.
- Headquarter Oldsmar, United States
- Employees 82 as on 30 Nov, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cryo-Cell International, Inc.
-
Annual Revenue
$31.99 M2.05as on Nov 30, 2024
-
Net Profit
$402.1 K0as on Nov 30, 2024
-
EBITDA
$4.81 M228.85as on Nov 30, 2024
-
Latest Funding Round
$1.8 M (USD), Post-IPO
Dec 02, 1999
-
Investors
-
Employee Count
82
as on Nov 30, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cryo-Cell
Cryo-Cell is a publicly listed company on the AMEX with ticker symbol CCEL in USA, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Medical Team
2 people
Software Development Team
1 people
Leadership Team
1 people
CIO Team
1 people
Unlock access to complete
Funding Insights of Cryo-Cell
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $1.8M
-
First Round
First Round
(01 Nov 1999)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 1999 | Amount | Post-IPO - Cryo-Cell | Valuation |
investors |
|
| Nov, 1999 | Amount | Post-IPO - Cryo-Cell | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Cryo-Cell
Cryo-Cell has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CORD:USE Cord Blood. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of umbilical cord blood stem cell storage services
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cryo-Cell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cryo-Cell Comparisons
Competitors of Cryo-Cell
Cryo-Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as China Cord Blood Corporation, BioLife Plasma Services, Cellcolabs, FamilyCord and Lazo de Vida, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Umbilical cord blood stem cell banking services are provided.
|
|
| domain | founded_year | HQ Location |
BioLife Plasma Services collects high-quality plasma and processes it into lifesaving therapies.
|
|
| domain | founded_year | HQ Location |
Stem cell banking services are provided for the healthcare sector.
|
|
| domain | founded_year | HQ Location |
Provides comprehensive stem cell storage services for individuals.
|
|
| domain | founded_year | HQ Location |
Provider of stem cell banking services
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cryo-Cell
Frequently Asked Questions about Cryo-Cell
When was Cryo-Cell founded?
Cryo-Cell was founded in 1989 and raised its 1st funding round 10 years after it was founded.
Where is Cryo-Cell located?
Cryo-Cell is headquartered in Oldsmar, United States. It is registered at Oldsmar, Florida, United States.
How many employees does Cryo-Cell have?
As of Nov 30, 2024, the latest employee count at Cryo-Cell is 82.
What is the annual revenue of Cryo-Cell?
Annual revenue of Cryo-Cell is $31.99M as on Nov 30, 2024.
What does Cryo-Cell do?
Cryo-Cell is a cord blood bank to separate and store stem cells. The company services include umbilical cord blood, cord tissue, and menstrual stem cell banking. The premium service includes cryopreservation of cord tissue mesenchymal stem cells that can differentiate into bone, muscle, fat, and cartilage tissue.
Who are the top competitors of Cryo-Cell?
Cryo-Cell's top competitors include China Cord Blood Corporation, Cellcolabs and Lazo de Vida.
Is Cryo-Cell publicly traded?
Yes, Cryo-Cell is publicly traded on AMEX under the ticker symbol CCEL.
How many acquisitions has Cryo-Cell made?
Cryo-Cell has made 1 acquisition, including CORD:USE Cord Blood.
What is Cryo-Cell's ticker symbol?
The ticker symbol of Cryo-Cell is CCEL on AMEX.